Investors Clamor for Generic Drug ETF

Big pharma will soon lose patents on blockbuster drugs, boosting the market for cheap generic drug producers. Too bad there isn’t an exchange traded fund that tracks global generic drug makers. The cheap generic drug market could account for $29 billion in total revenue as about 120 drugs...